The Value of Apparent Diffusion Coefficient in Determining Gleason Score of Prostate Cancer
Main Article Content
Abstract
Objective: The objective of the study is to evaluate the correlation and value of apparent diffusion coefficient (ADC) in determining the Gleason score of prostate cancer (PC).
Subjects and methods: From January 2023 to December 2024, 39 patients were diagnosed and had histopathological results of PC, who had undergone prostate MRI before. We evaluated the correlation between the ADC value and the Gleason score using Spearman's correlation coefficient, then compared the ADC value between two groups of clinical insignificance (Gleason =6) and clinical significance PC (Gleason >6) by using Mann-Whitney test. The ROC curve was used to find the ADC value in distinguishing clinical insignificance and significance PC.
Results: The average age of patients was 75.8 ± 7.3 years. The mean gland volume was 48.4 ± 25.4 grams. 62% of PC originated from the peripheral region, 38% originated from the central glandular region. 7.7% of patients had a Gleason score = 6, 92.3% of patients had a Gleason score > 6. The ADC value at the lesion was strongly negatively correlated with the Gleason score, with Spearman's correlation coefficient = -0.619 (p = 0.000). The mean ADC value of the Gleason =6 group was 1194.33 ± 41.9 s/mm2, statistically higher than that of the Gleason >6 group at 802.3 ± 115.4 s/mm2 (p <0.05). ROC curve analysis showed that with an ADC threshold of 1093.5 s/mm2, diffusion MRI was able to differentiate clinically insignificant and significant PC with a sensitivity of 100% and a specificity of 97.2%.
Conclusion: ADC values were significantly correlated with Gleason scores and were able to predict clinically insignificant and significant PC.
Keywords: prostate cancer, clinically significant, apparent diffusion coefficient, Gleason score.
Keywords
prostate cancer, clinically significant, apparent diffusion coefficient, Gleason score.
Article Details
References
2. Borza, T., R. Konijeti, and A.S. Kibel, Early detection, PSA screening, and management of overdiagnosis. Hematol Oncol Clin North Am, 2013. 27 (6): p. 1091-110, vii.
3. Kasivisvanathan, V., et al., MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med, 2018. 378 (19): p. 1767-1777.
4. Woo, S., et al., Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score. AJR Am J Roentgenol, 2016. 207 (1): p. 114-20.
5. Itatani, R., et al., Clinical utility of the normalized apparent diffusion coefficient for preoperative evaluation of the aggressiveness of prostate cancer. Jpn J Radiol, 2014. 32 (12): p. 685-91.
6. Phạm, T.H., et al., Correlation between apparent diffusion coefficient on diffusion-weighted imaging and prostatespecific antigen levels with gleason histological grading in prostate cancer. Vietnamese Journal of Radiology and Nuclear Medicine, 2024(56): p. 48-55.
7. Bengtsson, J., et al., Correlation between ADC, ADC ratio, and Gleason Grade group in prostate cancer patients undergoing radical prostatectomy: Retrospective multicenter study with different MRI scanners. Front Oncol, 2023. 13: p. 1079040.
8. Verma, S., et al., Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. AJR Am J Roentgenol, 2011. 196 (2): p. 374-81.
9. Hambrock, T., et al., Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology, 2011. 259 (2): p. 453-61.
10. Nguyen, T.B., et al., Utility of quantitative apparent diffusion coefficient measurements and normalized apparent diffusion coefficient ratios in the diagnosis of clinically significant peripheral zone prostate cancer. Br J Radiol, 2018. 91 (1088): p. 20180091.
11. Weinreb, J.C., et al., PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol, 2016. 69 (1): p. 16-40.
12. Surov, A., H.J. Meyer, and A. Wienke, Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review. Eur Urol Oncol, 2020. 3 (4): p. 489-497.
13. Bajgiran, A.M., et al., Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI. AJR Am J Roentgenol, 2019. 213 (3): p. W134-w142.